Microplastics and the gut: a review highlights the limits of laboratory models

Mapping experiments, not measuring human risk

The researchers conducted a scoping review, a method designed to map a research field and its gaps. Their search of PubMed, Scopus and Web of Science selected 90 peer-reviewed experimental studies from 3,540 initially identified references.

The studies focused on mammalian intestinal models: cell systems, tissues studied outside the body and experiments on living organisms. However, in vitro studies accounted for 80 of the 90 publications, or 88.9% of the dataset. This review therefore does not demonstrate clinical effects in people exposed in their everyday lives.

Biological signals, but a narrow range of models

The most frequently studied topics included oxidative stress, mitochondrial damage, particle uptake and passage, changes in intestinal permeability, and inflammatory responses. Responses related to cell death or DNA damage were also studied. The abstract provides no pooled estimate of the magnitude of these effects.

Systems using Caco-2 cells dominated the dataset, accounting for 47 of the 90 studies. This concentration allows certain mechanisms to be explored, but limits the diversity of biological situations represented. A finding from a cell model cannot, on its own, predict disease in humans.

The particles studied do not cover the full range of real-world exposure

Polystyrene appeared in 54 of the 90 studies. Nanoplastics were also studied in 54 publications, and 62 studies used pristine particles. Knowledge is therefore concentrated on certain materials and particle conditions, rather than spread across their full environmental diversity.

The authors also highlight the heterogeneity of particle sizes, exposure scenarios and biological endpoints measured. Their priorities are to broaden the range of intestinal models, use more environmentally relevant polymers and better standardize particle characterization.

What you can reasonably take away

This review documents potential mechanisms that warrant further investigation. It cannot quantify your individual risk or identify a specific preventive measure. The key distinction remains between a disruption observed in an experimental system and a demonstrated health effect at human exposure levels.

What we can take away

Experimental models indicate possible biological effects on the gut. Their concentration on cell systems and a few particle types prevents these findings from being translated directly into human risk.